Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density
- PMID: 12796639
- DOI: 10.1097/01.ju.0000072422.69286.0e
Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density
Abstract
Purpose: We evaluated the clinical outcomes and risk factors for progression in a large cohort of patients with lymph node metastases following en bloc radical cystectomy and bilateral pelvic lymphadenectomy.
Materials and methods: From July 1971 through December 1997, 1,054 patients underwent radical cystectomy and bilateral pelvic-iliac lymphadenectomy for high grade, invasive transitional cell carcinoma of the bladder. Of these patients 244 (23%) with a median age of 66 years (range 36 to 90) had pathological lymph node metastases. Overall 139 of the 244 patients (57%) received some form of chemotherapy. At a median followup of greater than 10 years (range 0 to 28) outcomes data were analyzed in univariate analysis according to tumor grade, carcinoma in situ, primary bladder tumor stage, pathological subgroups, total number of lymph nodes removed and involved with tumor, and lymph node density (total number of positive lymph nodes/total number removed). In addition, the form of urinary diversion and the administration of chemotherapy were also evaluated. Multivariate analysis was then performed to analyze these variables independently.
Results: The incidence of positive lymph nodes increased with higher p stage and pathological subgroups. Of 669 patients 75 (11%) with organ confined primary tumors and 169 of 385 (44%) with extravesical tumor extension had involved lymph nodes. The median number of lymph nodes removed in the 244 lymph node positive cases was 30 (range 1 to 96), while the median number of positive lymph nodes was 2 (range 1 to 63). Overall recurrence-free survival at 5 and 10 years for the 244 patients with lymph node positive disease was 35% and 34%, respectively. Patients with lymph node positive disease and an organ confined primary bladder tumor had significantly improved 10-year recurrence-free survival compared with those with extravesical tumor extension (44% vs 30%, p = 0.003). The total number of lymph nodes removed at surgery was also prognostic. Patients with 15 or less lymph nodes removed had 25% 10-year recurrence-free survival compared with 36% when greater than 15 lymph nodes were removed. Recurrence-free survival at 10 years for patients with 8 or less positive lymph nodes was significantly higher than in those with greater than 8 positive lymph nodes (40% vs 10%, p <0.001). The novel concept of lymph node density was also a significant prognostic factor. Patients with a lymph node density of 20% or less had 43% 10-year recurrence-free survival compared with only 17% survival at 10 years when lymph node density was greater than 20% (p <0.001). On multivariate analysis the total number of lymph nodes involved, pathological subgroups of the primary bladder tumor, lymph node density and adjuvant chemotherapy remained significant and independent risk factors for recurrence-free and overall survival.
Conclusions: Patients with lymph node tumor involvement following radical cystectomy may be stratified into high risk groups based on the primary bladder tumor, pathological subgroup, number of lymph nodes removed and total number of lymph nodes involved. Lymph node density, which is a novel prognostic indicator, may better stratify lymph node positive cases because this concept collectively accounts for the total number of positive lymph nodes (tumor burden) and the total number of lymph nodes removed (extent of lymphadenectomy). Future staging systems and the application of adjuvant therapies in clinical trials should consider applying lymph node density to help standardize this high risk group of patients following radical cystectomy.
Similar articles
-
Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.J Urol. 2007 Oct;178(4 Pt 1):1218-23; discussion 1223-4. doi: 10.1016/j.juro.2007.05.160. Epub 2007 Aug 14. J Urol. 2007. PMID: 17698113
-
The association between extent of lymphadenectomy and survival among patients with lymph node metastases undergoing radical cystectomy.Cancer. 2008 Jun;112(11):2401-8. doi: 10.1002/cncr.23474. Cancer. 2008. PMID: 18383515
-
Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.J Urol. 2006 Dec;176(6 Pt 1):2414-22; discussion 2422. doi: 10.1016/j.juro.2006.08.004. J Urol. 2006. PMID: 17085118
-
The role of lymphadenectomy in high-grade invasive bladder cancer.Urol Clin North Am. 2005 May;32(2):187-97. doi: 10.1016/j.ucl.2005.01.005. Urol Clin North Am. 2005. PMID: 15862616 Review.
-
Local recurrence after radical cystectomy for invasive bladder cancer: an analysis of predictive factors.Urology. 2004 Oct;64(4):744-8. doi: 10.1016/j.urology.2004.05.003. Urology. 2004. PMID: 15491713 Review.
Cited by
-
The Usefulness of Lymphadenectomy in Bladder Cancer-Current Status.Medicina (Kaunas). 2021 Apr 25;57(5):415. doi: 10.3390/medicina57050415. Medicina (Kaunas). 2021. PMID: 33922894 Free PMC article. Review.
-
Occult Metastases in Pelvic Lymphadenectomy Specimens From Patients With Urothelial Carcinoma of the Bladder.Urology. 2016 Aug;94:161-6. doi: 10.1016/j.urology.2016.03.058. Epub 2016 May 13. Urology. 2016. PMID: 27184604 Free PMC article.
-
How many lymph nodes are enough? Assessing the adequacy of lymph node yield for staging in favorable histology wilms tumor.J Pediatr Surg. 2019 Nov;54(11):2331-2335. doi: 10.1016/j.jpedsurg.2019.06.010. Epub 2019 Jun 20. J Pediatr Surg. 2019. PMID: 31255328 Free PMC article.
-
Does the greater number of lymph nodes removed during standard lymph node dissection predict better patient survival following radical cystectomy?World J Urol. 2011 Aug;29(4):443-9. doi: 10.1007/s00345-011-0644-9. Epub 2011 Jan 15. World J Urol. 2011. PMID: 21240505
-
Outcome following radical cystectomy and bladder-preservation therapy in patients with invasive carcinoma of urinary bladder.Indian J Urol. 2008 Jan;24(1):48-53. doi: 10.4103/0970-1591.38603. Indian J Urol. 2008. PMID: 19468359 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials